2. To find admission lactate reference level which is attributed to significant increase of mortality. 3. To compare with other markers and scoring systems like: PCT (procalcitonin), CRP (C-reactive protein), CURB-65 (pneumonia severity score), APACHEII (Acute Physiology and Chronic Health Evaluation II). Material and methods. This is a retrospective observational study in which data were collected on all patients admitted to ICUwith pneumonia and sepsis and/or septic shock in two major Hospitals of Republic of Latvia (Eastern Clinical university hospital and Pauls Stradins Clinical university hospital) with primary diagnosis of severe community acquired pneumonia (CAP). We compared the relationship between lactate values that were collected in 24 hour period after admission in ICU and ICU mortality. Results. In this study we analyzed data from consecutive 73 patients with severe CAP and sepsis and/or septic shock and we observed statistically significant difference between the first lactate level (LAC 1 ) in survivors (2.7 [1.9-3.2] (mmol/l) and nonsurvivors 4.9 [4.3-7.5] (mmol/l); p<0.001).According to data patients withLAC 1 <3.0 (mmol/l) mortality risk was 0%, patients with LAC 1 3.0 -4.0 (mmol/l) risk was 42.1%, while patients with LAC 1 >4.0 (mmol/l) mortality risk reached 89.7%. Lactate level measurements in first 24 hours after arrival into the ICU have had high ability to stratify non-survivor patients: LAC 1 (0.96), LAC 2 (0.98), LAC 3 (0.97), LAC 4 (0.92), (AUC). Incomparison with other prognostic markers sensitivity and specificity following results were obtained: CRP (0.59), PCT (0.98), APACHE II (0.98), CURB-65 (0.63). Conclusions. Summarizing data on patients with severe pneumonia and sepsis and/or septic shock admission lactate in first 24 hours have significant independent predictive value. In first 24 hours after admission in ICU higher mortality were observed if LAC 1 was >3 (mmol/l). Data proves for thepatients with severe pneumonia LAC 1 is having similar prognostic ability like APACHEII and PCT, and significantly better prognostic ability than CRP and CURB-65.
INTRODUCTION
According to data collected at 2010 for total mortality and causes of death in the world, lower respiratory tract infections are the cause of death in 2.8 million cases from 52.8 million. (Lozano, 2012) . Several sources show that 20-36% of patients with pneumonia requires hospitalization in ICU andfor them the risk of the mortality is above 70% (Wiemken, 2012; Peake, 2014; Moine, 1994) . For critically ill patients with a different reasons for shock high lactate levels at the beginning are associated with higher mortality risk (Gunnerson, 2006; Mikkelsen, 2009; Suistomaa, 2000) .Lactateis the end product of anaerobic glycolysis and for most patients with septic shock it rises due to tissue ischemia and insufficient oxygen supply. One of the most recent studies indicates that the starting lactate levels ≥4 (mmol/l) is associated with a high risk of mortality for trauma patients (Odom, 2014 ).
SUMMARY
Introduction. There are many discussions that one of the mortality risk markers for patients admitted to intensive care unit (ICU) with different etiology shock is admission blood lactate level. It is believed that serum lactate could be used as an early marker of mortality risk determination. We are not aware about research studies regarding admission serum lactate prognostic significance in patients with severe community acquired pneumonia (CAP) in first 24 hours after admission to ICU in Latvia. Aim of the study. 1. To evaluate the prognostic significance of the first lactate level in patients with severe pneumonia. To compare the statistical data of different blood lactate levels (LAC 1 , LAC 2 , LAC 3 , LAC 4 , LAC MAX , LAC MIN ).
The prognostic importance of the initial lactate levels in critically ill patients with a different shock etiologies were showed in one of the first studies about lactate levels. This study indicated that for those patients who had their lactate levels >3.83 mmol/l they were associated with 67% mortality, while those who had <3.83 (mmol/l), with only 25% mortality rate. (Cady, 1973) . Increase in lactate level can be observed even before any significant changes in the vital indicators. (Bernardin, 1996; Shapiro, 2005) . Moreover, early detection gives a broader assessment of the patientcondition and the opportunity of an early initiation of adequate treatment, which reduces in-hospital mortality rate (Jansen, 2010) . Surviving Sepsis guidelines, updated in 2012, points out the fact that serum lactate level is a very important indicator for the severity of sepsis. It recommends to measure lactate serum levels in the first three hours after admission and to achieve its normalization as quickly as possible (Dellinger, 2013 
RESULTS

Characteristics of the study population
Medical records were analyzed for 73 ICU patients who were hospitalized in the intensive care unit due to relative hypovolemia and respiratory failure. The mean age of patients was 63.2 (± 16.6) years. The study included 41 male and 32 female.34 (48.6%) patients died in the ICU with a mean age of 69.7 (± 16.6), including 14 (41.2%) women and 20 (58.8%) men. Of these 34 deaths, the youngest patient was 28 years old whereas the oldest had 93 years.Characteristicsof the two groups are seen in Table 1 . Lactate level analysis was done with Mann-Whitney U test. The results are seen in Table 2 . 1 2,7 (1,9-3,2) 4,9 (4,3-7.5) 0,001 LAC 2 2,0 (1,7-2,4) 4,0 (4,0-6,0) 0,001 LAC 3 2,0 (1,9-2,0) 4,0 (2,9-5,6) 0,001 LAC 4 2,0 (2,0-2,0)
The obtained serum lactate values The first measurement of serum lactate (LAC 1 ) was carried out in the first hour of hospitalization in the ICU. The study showed statistically significant differences between survivors and deceased patients in first and all subsequent measurements (second, third and fourth). The biggest difference in lactate median values between survivors and deceased patients were observed in the first measurement, and over time the difference tended to decrease. The maximum and minimum median of lactate levels for surviving patients was lower than that of the not survivors. Patients who LAC1 level were 3.0 to 4.0 (mmol/ l) the mortality risk was 42.1%, while if LAC1 level was>4.0 (mmol / l) mortality risk was 89.7% (see. Table 3 ). In the group of not survivors, 26 (76%) of patients had LAC1 ≥4,5 (mmol/l), and these patients average length of stay in the ICU was 3.8 days. In addition, seven of them died in the first day, 13 patients during the first three days and 22 in during the first week. While if LAC1 was> 8 (mmol / l), which was registered in 6 dead patients, the average number of days spent in the ICU had dropped to 2.16 days.
Dynamics of lactate level measurements
Second lactate level measurements for non-survivors are performed earlier than in survivors, respectively after four hours (3-7) in non-survivor group and after six hours(5-9) in survivors group (p = 0.007).Interval of time in hours (h) between the second and third lactate level (LAC 2-3 ) as well as third and fourth measurement (LAC [3] [4] ) is similar to the non-survivor and to survivor patient groups. 
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Characteristics of lactate level discriminatory capacityof the survival prognosis in ICU ROC curves were made and area under the curve (AUC) were compared with lactate concentration characteristics (Tab 5) in order to assess the predictive ability of lactate level to separate survivor group from not survivors for ICU patients with severe pneumonia during the first 24 hours. 
Other prognostic markers
The results show that all the lactate measured during the first 24 hours is a good prognostic marker (Fig. 2) . Inaccurate markers are CRP (0.60), CURB-65 (0.63), but significantly more accurate PCTs (0.98) APACHEII (0.98) LAC1 (0.96) (Fig 1) . White blood cell count <3 (10 ^ 9 / l) are noted for 16 patients, but> 15 (10 ^ 9 / l) in one patient in not survived patient group. Surviving patients, respectively, leukocytosis had five patients, but leukopenia nil. 
DISCUSSION
The study retrospectively analyzed 73 patients with severe pneumonia. After they were admitted to ICU lactate level was measured 2-4 times to determine lactate levels in the blood. The aim was to investigate whether initial lactate levels are an important prognostic indicator of mortality in patients with severe pneumonia during the first 24 hours. The study defined sepsis as a verified or expected infection with ≥2 SIRS criteria, that is accepted to use in the diagnosis of sepsis (Dellinger, 2013 ; Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, 1992). There is a presumption that in the case of septic shock lactate level elevations are associated with multifactorial etiology, however, it is demonstrated that lactate levels for critically ill patients with septic shock is a good warning signal for the early and effective start of treatment (Rivers, 2001 ). Chertoff et al study, collected data show that lactate kinetics is particularly prognostic significance directly early stages of sepsis (Chertoff, 2015) . It is therefore important to determine lactate levels as quickly as possible. It could be considered as a routine practice to check for lactate level in venous blood before hospitalization to ICU. This will accelerate early and effective treatment initiation in patients with severe pneumonia. In this study for patients with severe pneumonia and LAC 1 > 4 (mmol /l), there is a significant increase in mortality risk. Lactate level could be used as atool for initiation of effective therapy in patients with severe pneumonia and closer
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Source of the Curve (most likely invasive) monitoring and higher levels of care. In addition, surviving patients had no one who LAC 1 > 4.5 (mmol /l). The best ability to distinguish potentially non-survivors LAC MAX patients was observed, however, the maximum lactate in the first 24 hours is not necessarily the first measurement of lactate, which limits the role of the forecast already at the time of hospitalization. The best prognosis was observed if LAC 1 was 2-4 (mmol/l). Out of all these patients a more favorable prognosis were associated with lower initial lactate level. Some patients may not always require admission to the ICU, if their lactate levels were > 4 (mmol/l), and not requiring respiratory, cardiovascular or any other organ support. Regardless of the time lactate measurement were taken in the first 24 hours, it is a good prognostic marker. In comparison with the other characteristics LAC 1 is similar to PCT and APACHE II. For APACHE II scale need quite a lot of characteristics and PCT quantification is longer and more expensive, so practically lactate is easier to use. It is possible that patients in non-survivor group from the very beginning were presenting with more severe clinical condition and that is why these patients had higher lactate levels in the first place and good results with "correct" treatment was harder to reach. Due to the fact that patients therapy was not analyzedit is impossible to evaluate effectiveness of therapy used in each case. Etiological agent was not analyzed because approximately in half of the cases it was not found which is similar to data from other scientific papers (Peake, 2014) . In this research authors wanted to emphasize the significance of metabolic factors independently from etiological agent, which in most cases is not identified in the first 24 hours. We analyzed patients with Community Acquired Pneumonia, which is why the results of the study cannot be associated with other etiology pneumonias like Hospital-acquired Pneumonia, Health care-acquired pneumonia, Aspiration pneumonia. In this study medications that patients might had received at home before hospitalization were not analyzed. This can influence a serum lactate levels, like metformin, epinephrine or any other sypathomimetics and other hyperlactataemia inducing agents. Although chronic heart failure can chronically increase lactate levels, two patients were included in the research that does not change the general results and conclusions. Also in this study we did not find a statistically reliable correlation between CURB-65 and the outcome. That can be explained with the fact that average age of patients in this study was under 65, respiratory rate often did not reach 30 times per minute, and most of the patients GCS was more than 8. Analyzing the significance of CURB-65 in fast evaluation in severity of pneumonia, some may question the importance/significanse of Urea in this scale. Authors suggest to add laboratorial markers, which potentially can be more significant in evaluation of severity of pneumonia, like White Cell Count and Serum lactate levels. We did not find statistically reliable correlation between CRP and outcome which is similar to other research data, but PCT is a very good prognostic marker (Heper, 2006) . This study can not define the specific serum lactate border value to evaluate which patients should be admitted to ICU. This border value could be lower than it is used to be defined, even if the first lactate measurement is >2 mmol/L. In the future it would be worthy to analyze dynamic lactate levels and their correlation with outcome and to make a prospective study that would allow us to analyze all the therapeutic, toxic, pre hospital and other factors that could influence lactate levels in each specific case. An also it would be useful to explore also oxygenation and saturation in prospective study. has a similar prognostic ability with APACHE II and PCT scales and they are better than CRP and CURB-65. 4. Early lactate level measurement before admission to ICU can help stratify patients with high risk of mortality.
CONCLUSIONS
